News About: Pharm. Industry
Drug company year end incentive plans less than past years
Most of local pharmaceutical companies provided less incentive plans for the year end by lunar calendar this year than the past for their customers to induce and pay greetings.
Boryung offers a Korean traditional ...
Biocore to patent a test for cervical cancer.
Biocore announced on Jan. 2 that a genetic diagnostic method of HPV infection was patented in Korea, which was newly designed by the use of a suspension array microsphere bead unlike the conventional DNA chip method.
...
Janssen's full clinical studies to put on new schizophrenia drug.
Janssen Korea put a full clinical study for the new generation of schizophrenia drug, Paliperidone, especially focusing on 5 of phase III studies at 20 test centers and 1 of phase I study, the total 6 studies in Korea...
Daewoong to enter major vaccine business from Feb.
Daewoong announced to engage in the vaccine business as a company major project by launching a PDT vaccine in a pre-filled syringe type, in coming February after establishing a specialized product line with the syring...
59 drug companies including foreigners were prosecuted.
59 drug companies including the foreign multinational drug corporations were prosecuted on charge of breaching the Pharmaceutical Affairs Act including drug quality problems.
The Seoul Regional KFDA supervised the ...
A new type of drug logistic cooperation to visualize.
A new type of drug logistic cooperation seems to be in shape soon.
According to an information released by the pharmaceutical wholesalers and its related business circles on Jan. 20, a legislation bill for the esta...
Sales of foreign multinational drug corporations on remarkable growth.
The rank of foreign drug corporations in terms of the 2005 sales volume seems to be changed and it is clear that a company selling over the level of 300 billion won may appear for the first since their business entrie...
GSK to achieve more than 300 BW of sales in 2005.
GSK generated a remarkable sales during 2005 at 302.5 BW, 26% up from the previous year, thank to their diverse marketing promotional activities with affluent manpower and pipeline products and efficient utilization o...
Lilly Korea to launch super speedy pen type of insulin.Lilly Korea announced on Jan. 19 to launch Humalog Mix 25, a pen type of insulin having a similar physiological profile of human body to control the blood sugar.
Lilly Korea ...
|
Newgenpharm to acquire license for cancer gene therapy.
Newgenpharm announced to acquire "Celagen" an anti-cancer gene therapy from Henry Ford hospital in the United States, which was scheduled to commercialize until 2008.
Dr. Kim Jae-ho and colleagues of Henry Ford hos...
